| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Barrett Esophagus | 11 | 2009 | 495 | 1.580 |
Why?
|
| Colitis | 23 | 2024 | 1244 | 1.460 |
Why?
|
| Intestinal Mucosa | 25 | 2023 | 3047 | 0.960 |
Why?
|
| Esophagogastric Junction | 6 | 2009 | 351 | 0.940 |
Why?
|
| Gastritis | 5 | 2015 | 199 | 0.940 |
Why?
|
| Metaplasia | 8 | 2007 | 326 | 0.720 |
Why?
|
| Gastric Mucosa | 7 | 2015 | 602 | 0.680 |
Why?
|
| Colitis, Ulcerative | 12 | 2022 | 1931 | 0.610 |
Why?
|
| Epithelium | 7 | 2009 | 1607 | 0.580 |
Why?
|
| Helicobacter Infections | 3 | 2015 | 390 | 0.570 |
Why?
|
| Colon | 19 | 2024 | 1804 | 0.560 |
Why?
|
| Cardia | 3 | 2007 | 61 | 0.550 |
Why?
|
| Helicobacter pylori | 3 | 2015 | 380 | 0.540 |
Why?
|
| Stomach | 3 | 2015 | 702 | 0.530 |
Why?
|
| Colorectal Neoplasms | 15 | 2024 | 6982 | 0.480 |
Why?
|
| Mucins | 4 | 2010 | 571 | 0.440 |
Why?
|
| Fusobacterium nucleatum | 3 | 2021 | 176 | 0.430 |
Why?
|
| Keratins | 6 | 2005 | 502 | 0.420 |
Why?
|
| Esophageal Neoplasms | 5 | 2007 | 1674 | 0.410 |
Why?
|
| Immunity, Mucosal | 5 | 2019 | 498 | 0.400 |
Why?
|
| Esophagus | 5 | 2008 | 1043 | 0.390 |
Why?
|
| Pathology, Surgical | 2 | 2023 | 150 | 0.390 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 6 | 2024 | 1105 | 0.380 |
Why?
|
| Adenocarcinoma | 8 | 2018 | 6401 | 0.360 |
Why?
|
| Colonic Neoplasms | 6 | 2020 | 2543 | 0.350 |
Why?
|
| Th17 Cells | 3 | 2023 | 791 | 0.350 |
Why?
|
| Adenoma | 6 | 2022 | 2164 | 0.330 |
Why?
|
| Intestines | 7 | 2022 | 1911 | 0.330 |
Why?
|
| Gastroesophageal Reflux | 6 | 2009 | 836 | 0.320 |
Why?
|
| Intermediate Filament Proteins | 3 | 2005 | 262 | 0.310 |
Why?
|
| T-Box Domain Proteins | 8 | 2015 | 472 | 0.310 |
Why?
|
| Rectum | 5 | 2018 | 900 | 0.310 |
Why?
|
| Tissue Fixation | 3 | 2008 | 245 | 0.300 |
Why?
|
| Mice | 70 | 2024 | 82074 | 0.300 |
Why?
|
| Biopsy | 14 | 2024 | 6805 | 0.290 |
Why?
|
| Immunohistochemistry | 19 | 2015 | 11119 | 0.290 |
Why?
|
| Pleural Neoplasms | 6 | 2009 | 612 | 0.280 |
Why?
|
| Esophageal Diseases | 2 | 2005 | 168 | 0.280 |
Why?
|
| Receptors, Fc | 3 | 2020 | 538 | 0.270 |
Why?
|
| Mesothelioma | 7 | 2009 | 811 | 0.270 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2020 | 1363 | 0.270 |
Why?
|
| Pancreatic Neoplasms | 11 | 2020 | 5443 | 0.260 |
Why?
|
| Inflammatory Bowel Diseases | 8 | 2024 | 2445 | 0.260 |
Why?
|
| Mice, Knockout | 26 | 2023 | 14485 | 0.250 |
Why?
|
| Dendritic Cells | 7 | 2020 | 2748 | 0.250 |
Why?
|
| Animals | 78 | 2024 | 169408 | 0.230 |
Why?
|
| Receptors, Cell Surface | 3 | 2021 | 2820 | 0.220 |
Why?
|
| Fatty Liver | 3 | 2024 | 810 | 0.220 |
Why?
|
| Precancerous Conditions | 3 | 2007 | 985 | 0.220 |
Why?
|
| Carcinoma, Pancreatic Ductal | 5 | 2020 | 1756 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 22 | 2024 | 22381 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 20 | 2020 | 20776 | 0.210 |
Why?
|
| Stomach Diseases | 1 | 2003 | 134 | 0.200 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2022 | 29 | 0.200 |
Why?
|
| Inflammation | 14 | 2024 | 10869 | 0.190 |
Why?
|
| Endometriosis | 2 | 2020 | 874 | 0.190 |
Why?
|
| Antigens, CD1d | 5 | 2018 | 225 | 0.190 |
Why?
|
| Interleukin-17 | 2 | 2021 | 925 | 0.190 |
Why?
|
| Helicobacter | 1 | 2021 | 111 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2003 | 4064 | 0.190 |
Why?
|
| Heme | 1 | 2023 | 316 | 0.180 |
Why?
|
| Hemolysis | 1 | 2023 | 417 | 0.180 |
Why?
|
| Tryptophanase | 1 | 2020 | 6 | 0.180 |
Why?
|
| Mannose-Binding Lectins | 1 | 2021 | 101 | 0.180 |
Why?
|
| Humans | 131 | 2024 | 768887 | 0.180 |
Why?
|
| Digestive System | 1 | 2001 | 244 | 0.180 |
Why?
|
| Receptors, CCR2 | 1 | 2022 | 216 | 0.180 |
Why?
|
| Epithelial Cells | 5 | 2022 | 3701 | 0.180 |
Why?
|
| Disease Models, Animal | 26 | 2024 | 18366 | 0.180 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2020 | 67 | 0.180 |
Why?
|
| Liver | 9 | 2024 | 7579 | 0.170 |
Why?
|
| Cilia | 1 | 2024 | 498 | 0.170 |
Why?
|
| Listeriosis | 1 | 2021 | 147 | 0.170 |
Why?
|
| Gastroscopy | 1 | 2001 | 213 | 0.170 |
Why?
|
| Cysts | 2 | 2024 | 685 | 0.170 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 2665 | 0.170 |
Why?
|
| Lymphocytes | 3 | 2020 | 2614 | 0.170 |
Why?
|
| Trans-Activators | 3 | 2009 | 2858 | 0.170 |
Why?
|
| Escherichia coli | 4 | 2023 | 4212 | 0.160 |
Why?
|
| DNA, Neoplasm | 2 | 2007 | 1748 | 0.160 |
Why?
|
| Tretinoin | 1 | 2022 | 525 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 14 | 2017 | 6232 | 0.160 |
Why?
|
| Enterobacteriaceae | 2 | 2010 | 161 | 0.160 |
Why?
|
| Oligosaccharides | 1 | 2021 | 407 | 0.160 |
Why?
|
| Immunity, Innate | 4 | 2020 | 3080 | 0.160 |
Why?
|
| Disease Susceptibility | 6 | 2024 | 1794 | 0.160 |
Why?
|
| Carcinoembryonic Antigen | 3 | 2006 | 338 | 0.160 |
Why?
|
| Bacteria | 5 | 2024 | 2219 | 0.160 |
Why?
|
| Abdominal Wall | 1 | 2020 | 166 | 0.160 |
Why?
|
| Female | 84 | 2024 | 397464 | 0.150 |
Why?
|
| Male | 73 | 2024 | 365249 | 0.150 |
Why?
|
| Diagnosis, Differential | 15 | 2020 | 13020 | 0.150 |
Why?
|
| Genetic Markers | 2 | 2007 | 2604 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 3 | 2017 | 1133 | 0.150 |
Why?
|
| Germ-Free Life | 4 | 2024 | 187 | 0.150 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 3951 | 0.150 |
Why?
|
| Microsatellite Instability | 2 | 2020 | 726 | 0.150 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 593 | 0.150 |
Why?
|
| Mast Cells | 3 | 2010 | 1406 | 0.150 |
Why?
|
| Smad4 Protein | 1 | 2018 | 193 | 0.150 |
Why?
|
| Eosinophils | 1 | 2022 | 953 | 0.140 |
Why?
|
| DNA-Binding Proteins | 14 | 2015 | 9618 | 0.140 |
Why?
|
| Middle Aged | 51 | 2024 | 223740 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2021 | 1248 | 0.140 |
Why?
|
| Sigmoidoscopy | 3 | 2008 | 150 | 0.140 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2017 | 94 | 0.140 |
Why?
|
| Glycoproteins | 2 | 2021 | 2202 | 0.140 |
Why?
|
| Gastrointestinal Neoplasms | 4 | 2012 | 957 | 0.140 |
Why?
|
| Oxazoles | 1 | 2018 | 199 | 0.140 |
Why?
|
| Gene Expression Profiling | 8 | 2009 | 9549 | 0.140 |
Why?
|
| Gallstones | 2 | 2010 | 285 | 0.140 |
Why?
|
| Membrane Proteins | 7 | 2021 | 7885 | 0.140 |
Why?
|
| Intestinal Diseases | 2 | 2013 | 505 | 0.130 |
Why?
|
| Esophagoscopy | 2 | 2009 | 398 | 0.130 |
Why?
|
| Natural Killer T-Cells | 3 | 2018 | 318 | 0.130 |
Why?
|
| Crohn Disease | 5 | 2019 | 2297 | 0.130 |
Why?
|
| Mice, Transgenic | 11 | 2023 | 9564 | 0.130 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2018 | 221 | 0.130 |
Why?
|
| Interleukins | 2 | 2020 | 796 | 0.130 |
Why?
|
| Intestinal Neoplasms | 3 | 2008 | 314 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2013 | 8664 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2020 | 36861 | 0.120 |
Why?
|
| Paneth Cells | 2 | 2013 | 100 | 0.120 |
Why?
|
| Lactococcus lactis | 1 | 2015 | 28 | 0.120 |
Why?
|
| Quorum Sensing | 1 | 2016 | 137 | 0.120 |
Why?
|
| Immunoglobulin A | 1 | 2019 | 992 | 0.120 |
Why?
|
| Dietary Proteins | 1 | 2020 | 960 | 0.120 |
Why?
|
| Muramidase | 1 | 2015 | 163 | 0.120 |
Why?
|
| Keratin-20 | 3 | 2005 | 31 | 0.120 |
Why?
|
| Th1 Cells | 2 | 2019 | 1042 | 0.120 |
Why?
|
| Fundoplication | 2 | 2007 | 145 | 0.120 |
Why?
|
| Muscle, Smooth | 3 | 2008 | 931 | 0.120 |
Why?
|
| Keratin-7 | 3 | 2005 | 55 | 0.120 |
Why?
|
| Autoimmunity | 2 | 2020 | 1360 | 0.120 |
Why?
|
| Graft vs Host Disease | 5 | 2006 | 3048 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2021 | 1024 | 0.120 |
Why?
|
| Aged | 36 | 2024 | 171790 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2005 | 1064 | 0.110 |
Why?
|
| Immunoglobulin G | 3 | 2020 | 4568 | 0.110 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2009 | 489 | 0.110 |
Why?
|
| Tomography, Spiral Computed | 3 | 2004 | 274 | 0.110 |
Why?
|
| Macrophages | 4 | 2023 | 5800 | 0.110 |
Why?
|
| Carrier Proteins | 6 | 2017 | 4940 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 3 | 2020 | 599 | 0.110 |
Why?
|
| Transcription Factors | 9 | 2013 | 12174 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 3 | 2009 | 1206 | 0.110 |
Why?
|
| Liver Cirrhosis | 4 | 2024 | 1962 | 0.110 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 400 | 0.110 |
Why?
|
| Reproducibility of Results | 10 | 2024 | 20244 | 0.110 |
Why?
|
| Homeostasis | 4 | 2022 | 3348 | 0.110 |
Why?
|
| Prognosis | 15 | 2022 | 30044 | 0.110 |
Why?
|
| DNA Methylation | 4 | 2020 | 4432 | 0.110 |
Why?
|
| Colonic Polyps | 2 | 2009 | 557 | 0.110 |
Why?
|
| Aspirin | 2 | 2021 | 3135 | 0.110 |
Why?
|
| Proctitis | 2 | 2003 | 40 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 2 | 2014 | 1614 | 0.110 |
Why?
|
| Genes, ras | 2 | 2008 | 665 | 0.110 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2014 | 146 | 0.110 |
Why?
|
| Carcinoma, Papillary | 3 | 2009 | 793 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 5 | 2008 | 1705 | 0.100 |
Why?
|
| Adult | 44 | 2024 | 223818 | 0.100 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 606 | 0.100 |
Why?
|
| Fatty Acids, Volatile | 1 | 2013 | 100 | 0.100 |
Why?
|
| Mucin-2 | 2 | 2009 | 50 | 0.100 |
Why?
|
| Interleukin-10 | 2 | 2018 | 1184 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2452 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 595 | 0.100 |
Why?
|
| Genes, p53 | 2 | 2006 | 716 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 1966 | 0.100 |
Why?
|
| Carcinoid Tumor | 2 | 2006 | 224 | 0.100 |
Why?
|
| Liver Neoplasms | 5 | 2008 | 4363 | 0.100 |
Why?
|
| Liver Diseases | 3 | 2024 | 1305 | 0.100 |
Why?
|
| Monocytes | 1 | 2022 | 2603 | 0.100 |
Why?
|
| Retrospective Studies | 21 | 2024 | 81892 | 0.100 |
Why?
|
| Neoplasm Proteins | 4 | 2009 | 3608 | 0.100 |
Why?
|
| Appendicitis | 2 | 2009 | 689 | 0.100 |
Why?
|
| Genomic Instability | 2 | 2007 | 715 | 0.100 |
Why?
|
| Lipoma | 2 | 2004 | 296 | 0.100 |
Why?
|
| Clinical Trials as Topic | 2 | 2024 | 8055 | 0.090 |
Why?
|
| Mutation | 7 | 2008 | 30266 | 0.090 |
Why?
|
| Malignant Carcinoid Syndrome | 2 | 2008 | 31 | 0.090 |
Why?
|
| Receptors, Virus | 1 | 2014 | 652 | 0.090 |
Why?
|
| Proteus mirabilis | 1 | 2010 | 24 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2018 | 9442 | 0.090 |
Why?
|
| T-Lymphocytes | 6 | 2014 | 10276 | 0.090 |
Why?
|
| Signal Transduction | 8 | 2023 | 23652 | 0.090 |
Why?
|
| Antigens, CD1 | 2 | 2004 | 434 | 0.090 |
Why?
|
| Chromosomes, Mammalian | 1 | 2011 | 148 | 0.090 |
Why?
|
| Receptors, IgG | 2 | 2020 | 564 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1891 | 0.090 |
Why?
|
| Hyperplasia | 4 | 2008 | 1154 | 0.090 |
Why?
|
| Microbial Interactions | 1 | 2010 | 74 | 0.090 |
Why?
|
| Bifidobacterium | 1 | 2010 | 99 | 0.090 |
Why?
|
| Antigens, CD | 3 | 2014 | 4032 | 0.090 |
Why?
|
| Feces | 4 | 2019 | 1511 | 0.090 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2010 | 65 | 0.090 |
Why?
|
| Gene Expression Regulation | 8 | 2015 | 11934 | 0.090 |
Why?
|
| Celiac Disease | 2 | 2009 | 820 | 0.090 |
Why?
|
| Observer Variation | 2 | 2024 | 2623 | 0.080 |
Why?
|
| Membrane Transport Proteins | 2 | 2008 | 1039 | 0.080 |
Why?
|
| Escherichia coli Proteins | 1 | 2016 | 1058 | 0.080 |
Why?
|
| Pancreas | 4 | 2009 | 1700 | 0.080 |
Why?
|
| Tryptases | 1 | 2010 | 176 | 0.080 |
Why?
|
| Cystic Fibrosis | 2 | 2010 | 1295 | 0.080 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2010 | 140 | 0.080 |
Why?
|
| Quantitative Trait Loci | 2 | 2024 | 2133 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2006 | 1714 | 0.080 |
Why?
|
| Metagenome | 1 | 2013 | 465 | 0.080 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2009 | 16 | 0.080 |
Why?
|
| Bone Marrow Cells | 2 | 2014 | 2414 | 0.080 |
Why?
|
| Bile | 1 | 2010 | 299 | 0.080 |
Why?
|
| Cromolyn Sodium | 1 | 2009 | 78 | 0.080 |
Why?
|
| Mucous Membrane | 2 | 2014 | 659 | 0.080 |
Why?
|
| Aged, 80 and over | 14 | 2015 | 59738 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 2 | 2006 | 121 | 0.080 |
Why?
|
| Aminosalicylic Acid | 1 | 2008 | 20 | 0.080 |
Why?
|
| Portal Vein | 2 | 2001 | 435 | 0.080 |
Why?
|
| Disease Progression | 8 | 2020 | 13677 | 0.080 |
Why?
|
| Taurocholic Acid | 1 | 2008 | 44 | 0.080 |
Why?
|
| Cholelithiasis | 1 | 2010 | 408 | 0.080 |
Why?
|
| Telomere | 2 | 2006 | 943 | 0.080 |
Why?
|
| Gallbladder | 1 | 2010 | 308 | 0.080 |
Why?
|
| Klebsiella pneumoniae | 1 | 2010 | 253 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2020 | 2055 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2008 | 1399 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2006 | 2960 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2008 | 2336 | 0.080 |
Why?
|
| Bilirubin | 1 | 2010 | 438 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 3 | 2019 | 875 | 0.070 |
Why?
|
| RNA, Neoplasm | 5 | 2008 | 751 | 0.070 |
Why?
|
| Contrast Media | 8 | 2020 | 5334 | 0.070 |
Why?
|
| RNA, Small Nuclear | 1 | 1988 | 71 | 0.070 |
Why?
|
| Biopsy, Needle | 4 | 2012 | 1627 | 0.070 |
Why?
|
| Lymphocyte Activation | 3 | 2019 | 5505 | 0.070 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2009 | 526 | 0.070 |
Why?
|
| Clathrin | 1 | 1989 | 258 | 0.070 |
Why?
|
| Mass Screening | 1 | 2003 | 5455 | 0.070 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 839 | 0.070 |
Why?
|
| Hepatic Veins | 1 | 2008 | 112 | 0.070 |
Why?
|
| Milk | 1 | 2010 | 440 | 0.070 |
Why?
|
| Ectodermal Dysplasia | 1 | 2008 | 107 | 0.070 |
Why?
|
| Lymphocytosis | 1 | 2008 | 121 | 0.070 |
Why?
|
| Immunity | 1 | 2013 | 1003 | 0.070 |
Why?
|
| Hematopoietic System | 1 | 2007 | 110 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2008 | 250 | 0.070 |
Why?
|
| Fatty Acid Desaturases | 1 | 2007 | 102 | 0.070 |
Why?
|
| Bile Ducts | 1 | 2008 | 288 | 0.070 |
Why?
|
| Diet | 3 | 2022 | 8090 | 0.070 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2006 | 304 | 0.070 |
Why?
|
| Brenner Tumor | 1 | 2006 | 9 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2009 | 462 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 631 | 0.070 |
Why?
|
| Oxazolone | 3 | 2014 | 61 | 0.070 |
Why?
|
| Frozen Sections | 1 | 2007 | 154 | 0.070 |
Why?
|
| Chilblains | 1 | 2006 | 17 | 0.070 |
Why?
|
| Ligands | 4 | 2021 | 3283 | 0.070 |
Why?
|
| Administration, Topical | 1 | 2008 | 704 | 0.070 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2008 | 173 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2297 | 0.070 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 200 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2012 | 617 | 0.060 |
Why?
|
| Polyps | 1 | 2007 | 200 | 0.060 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2005 | 73 | 0.060 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2005 | 71 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 12798 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2009 | 633 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 16051 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2014 | 2323 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 725 | 0.060 |
Why?
|
| Ribonucleoproteins | 1 | 1988 | 359 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2007 | 2813 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2005 | 82 | 0.060 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2006 | 189 | 0.060 |
Why?
|
| RNA, Messenger | 6 | 2008 | 12809 | 0.060 |
Why?
|
| Cell Differentiation | 7 | 2023 | 11684 | 0.060 |
Why?
|
| Kidney | 1 | 2020 | 7057 | 0.060 |
Why?
|
| Dextran Sulfate | 2 | 2020 | 258 | 0.060 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2006 | 304 | 0.060 |
Why?
|
| CpG Islands | 1 | 2009 | 1210 | 0.060 |
Why?
|
| Proline | 1 | 2006 | 455 | 0.060 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2006 | 171 | 0.060 |
Why?
|
| Statistics, Nonparametric | 3 | 2022 | 2862 | 0.060 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2008 | 550 | 0.060 |
Why?
|
| Child, Preschool | 8 | 2024 | 42684 | 0.060 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2005 | 62 | 0.060 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2008 | 391 | 0.060 |
Why?
|
| Mitosis | 2 | 2007 | 1181 | 0.060 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 2006 | 220 | 0.060 |
Why?
|
| Sensitivity and Specificity | 6 | 2020 | 14751 | 0.060 |
Why?
|
| Cytokines | 6 | 2021 | 7453 | 0.060 |
Why?
|
| Homeodomain Proteins | 3 | 2009 | 2431 | 0.060 |
Why?
|
| Virus Diseases | 1 | 2010 | 724 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 2238 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2008 | 5716 | 0.060 |
Why?
|
| Biliary Tract | 1 | 2024 | 135 | 0.060 |
Why?
|
| Lymphocyte Count | 2 | 2020 | 793 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2007 | 888 | 0.050 |
Why?
|
| Pancreatitis | 2 | 2008 | 1087 | 0.050 |
Why?
|
| Dermoid Cyst | 1 | 2004 | 92 | 0.050 |
Why?
|
| Esophagectomy | 1 | 2007 | 482 | 0.050 |
Why?
|
| Hemopexin | 1 | 2023 | 33 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2006 | 1143 | 0.050 |
Why?
|
| Genes, APC | 1 | 2003 | 146 | 0.050 |
Why?
|
| Pleura | 1 | 2004 | 248 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2007 | 764 | 0.050 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2023 | 51 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2009 | 1124 | 0.050 |
Why?
|
| Meckel Diverticulum | 1 | 2002 | 32 | 0.050 |
Why?
|
| Child | 13 | 2024 | 80969 | 0.050 |
Why?
|
| Vaginal Neoplasms | 1 | 2003 | 105 | 0.050 |
Why?
|
| Gastric Fundus | 1 | 2002 | 37 | 0.050 |
Why?
|
| Cystadenoma, Serous | 1 | 2003 | 100 | 0.050 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2004 | 115 | 0.050 |
Why?
|
| Adolescent | 13 | 2024 | 89247 | 0.050 |
Why?
|
| Antigens, Differentiation | 2 | 2004 | 921 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 627 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 4593 | 0.050 |
Why?
|
| Kidney Neoplasms | 2 | 2009 | 4300 | 0.050 |
Why?
|
| Atrophy | 1 | 2007 | 1647 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2023 | 2525 | 0.050 |
Why?
|
| Citrobacter rodentium | 1 | 2022 | 64 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 1 | 1988 | 1082 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2009 | 3811 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2008 | 1218 | 0.050 |
Why?
|
| Receptors, Cytokine | 1 | 2002 | 258 | 0.050 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2001 | 31 | 0.050 |
Why?
|
| Colitis, Ischemic | 1 | 2002 | 32 | 0.050 |
Why?
|
| Mice, Mutant Strains | 4 | 2007 | 1755 | 0.050 |
Why?
|
| Automation | 1 | 2024 | 589 | 0.050 |
Why?
|
| Proctocolitis | 1 | 2002 | 31 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 3613 | 0.050 |
Why?
|
| Fermentation | 2 | 2013 | 143 | 0.050 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 1780 | 0.050 |
Why?
|
| Acute Disease | 4 | 2009 | 7245 | 0.050 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2004 | 329 | 0.050 |
Why?
|
| Endpoint Determination | 1 | 2024 | 594 | 0.050 |
Why?
|
| Mesenteric Veins | 1 | 2001 | 87 | 0.050 |
Why?
|
| Necrosis | 2 | 2020 | 1621 | 0.050 |
Why?
|
| Neuroendocrine Tumors | 1 | 2008 | 657 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 3 | 2003 | 2709 | 0.050 |
Why?
|
| Embolism, Air | 1 | 2001 | 110 | 0.050 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2001 | 93 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2002 | 244 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2004 | 977 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2005 | 565 | 0.050 |
Why?
|
| Endoscopy, Digestive System | 1 | 2004 | 358 | 0.050 |
Why?
|
| Esophagitis | 1 | 2002 | 164 | 0.050 |
Why?
|
| Opportunistic Infections | 1 | 2004 | 375 | 0.050 |
Why?
|
| Gases | 1 | 2001 | 204 | 0.050 |
Why?
|
| Insulinoma | 1 | 2001 | 122 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 5 | 2010 | 6085 | 0.050 |
Why?
|
| Indican | 1 | 2020 | 16 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2007 | 4413 | 0.050 |
Why?
|
| Cholesterol | 1 | 2010 | 2913 | 0.050 |
Why?
|
| Ribavirin | 1 | 2003 | 395 | 0.050 |
Why?
|
| Hepatitis | 1 | 2003 | 228 | 0.050 |
Why?
|
| Pseudomonas Infections | 2 | 2002 | 623 | 0.050 |
Why?
|
| Neoplasm Staging | 5 | 2012 | 11262 | 0.040 |
Why?
|
| Mucus | 1 | 2022 | 346 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2006 | 562 | 0.040 |
Why?
|
| Mycoses | 1 | 2004 | 386 | 0.040 |
Why?
|
| Toxins, Biological | 1 | 2020 | 59 | 0.040 |
Why?
|
| Bile Duct Neoplasms | 1 | 2006 | 615 | 0.040 |
Why?
|
| Lectins | 1 | 2022 | 490 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2007 | 880 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2001 | 424 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2008 | 4042 | 0.040 |
Why?
|
| Diphtheria Toxin | 1 | 2021 | 253 | 0.040 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2004 | 592 | 0.040 |
Why?
|
| Lung | 3 | 2012 | 10097 | 0.040 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2004 | 326 | 0.040 |
Why?
|
| Germ Cells | 1 | 2024 | 644 | 0.040 |
Why?
|
| Interferon-gamma | 3 | 2022 | 3163 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2012 | 3538 | 0.040 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2003 | 335 | 0.040 |
Why?
|
| Gadolinium | 1 | 2005 | 965 | 0.040 |
Why?
|
| Ovarian Neoplasms | 3 | 2006 | 4919 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 13593 | 0.040 |
Why?
|
| Ligases | 1 | 2001 | 333 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 2565 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 3116 | 0.040 |
Why?
|
| Ganglioneuroma | 1 | 1999 | 53 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2008 | 1893 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2001 | 628 | 0.040 |
Why?
|
| RNA, Viral | 1 | 1988 | 2871 | 0.040 |
Why?
|
| Leiomyosarcoma | 1 | 2003 | 425 | 0.040 |
Why?
|
| Oncogenes | 1 | 2005 | 1236 | 0.040 |
Why?
|
| Predictive Value of Tests | 5 | 2009 | 15471 | 0.040 |
Why?
|
| Vascular Neoplasms | 1 | 2001 | 167 | 0.040 |
Why?
|
| Germ-Line Mutation | 2 | 2024 | 1887 | 0.040 |
Why?
|
| Hydrogen Sulfide | 1 | 2020 | 147 | 0.040 |
Why?
|
| Cell Proliferation | 5 | 2021 | 10486 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2020 | 182 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11886 | 0.040 |
Why?
|
| Abetalipoproteinemia | 2 | 2004 | 16 | 0.040 |
Why?
|
| Prolactinoma | 1 | 1999 | 114 | 0.040 |
Why?
|
| Asthma | 2 | 2012 | 6293 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2023 | 4356 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2021 | 2848 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2003 | 910 | 0.040 |
Why?
|
| Bacteroides | 1 | 2019 | 165 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 1739 | 0.040 |
Why?
|
| Autophagy | 2 | 2019 | 1351 | 0.040 |
Why?
|
| Chemokines | 2 | 2014 | 963 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2021 | 5404 | 0.040 |
Why?
|
| RNA Interference | 2 | 2018 | 2835 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 394 | 0.040 |
Why?
|
| Glycosylation | 1 | 2021 | 1101 | 0.040 |
Why?
|
| Ethanol | 1 | 2024 | 1332 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2024 | 684 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3473 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2020 | 332 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2022 | 708 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2019 | 290 | 0.040 |
Why?
|
| Severity of Illness Index | 6 | 2009 | 15955 | 0.040 |
Why?
|
| Vagina | 1 | 2003 | 848 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 726 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2009 | 3858 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1658 | 0.040 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 117 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 422 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2002 | 5803 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2002 | 1079 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 2149 | 0.040 |
Why?
|
| Genotype | 2 | 2024 | 13048 | 0.030 |
Why?
|
| Ultrasonography | 5 | 2009 | 6001 | 0.030 |
Why?
|
| Metabolome | 1 | 2024 | 1009 | 0.030 |
Why?
|
| Carbon Tetrachloride Poisoning | 2 | 2006 | 11 | 0.030 |
Why?
|
| Proteins | 2 | 2002 | 6011 | 0.030 |
Why?
|
| Flagella | 1 | 2016 | 97 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2020 | 4651 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2023 | 2234 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2023 | 1281 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2002 | 980 | 0.030 |
Why?
|
| Enteritis | 1 | 2017 | 164 | 0.030 |
Why?
|
| Tryptophan | 1 | 2018 | 482 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2009 | 3200 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2001 | 1866 | 0.030 |
Why?
|
| Catecholamines | 1 | 2016 | 390 | 0.030 |
Why?
|
| Hemangioma | 1 | 2001 | 727 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2019 | 549 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 906 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 733 | 0.030 |
Why?
|
| Plasma Cells | 1 | 2019 | 599 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2020 | 2059 | 0.030 |
Why?
|
| Alleles | 3 | 2019 | 6901 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 6856 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 3450 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1676 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 1891 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 4123 | 0.030 |
Why?
|
| Synaptophysin | 2 | 2009 | 140 | 0.030 |
Why?
|
| beta Catenin | 1 | 2020 | 1047 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2004 | 1560 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 12563 | 0.030 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2014 | 32 | 0.030 |
Why?
|
| HSP110 Heat-Shock Proteins | 1 | 2014 | 10 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 2003 | 1424 | 0.030 |
Why?
|
| Benzoic Acid | 1 | 2014 | 16 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2002 | 1276 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2010 | 9384 | 0.030 |
Why?
|
| Peptides | 1 | 2006 | 4353 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2008 | 18065 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2006 | 515 | 0.030 |
Why?
|
| Immunity, Active | 1 | 2013 | 58 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2023 | 54950 | 0.030 |
Why?
|
| Obesity | 2 | 2009 | 13087 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2018 | 1655 | 0.030 |
Why?
|
| Graft Survival | 1 | 2004 | 3888 | 0.030 |
Why?
|
| Remission Induction | 2 | 2014 | 2411 | 0.030 |
Why?
|
| Immune System | 1 | 2019 | 800 | 0.030 |
Why?
|
| Hepatocytes | 3 | 2006 | 1246 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 354 | 0.030 |
Why?
|
| Dexamethasone | 2 | 2015 | 1965 | 0.030 |
Why?
|
| eIF-2 Kinase | 1 | 2013 | 147 | 0.030 |
Why?
|
| Ischemia | 1 | 2001 | 1900 | 0.030 |
Why?
|
| Virulence | 1 | 2016 | 1298 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 4980 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2014 | 262 | 0.030 |
Why?
|
| Infant | 5 | 2009 | 36541 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2008 | 1151 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 2 | 2007 | 910 | 0.030 |
Why?
|
| Interleukin-23 | 1 | 2014 | 202 | 0.030 |
Why?
|
| Antibodies | 1 | 2001 | 2422 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2022 | 39394 | 0.030 |
Why?
|
| Chemokine CXCL6 | 1 | 2012 | 14 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2017 | 4148 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 4926 | 0.020 |
Why?
|
| Patient Selection | 1 | 2024 | 4265 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 3 | 2004 | 9264 | 0.020 |
Why?
|
| Receptors, CXCR | 1 | 2012 | 52 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1769 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2012 | 10115 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 220 | 0.020 |
Why?
|
| Adoptive Transfer | 2 | 2006 | 824 | 0.020 |
Why?
|
| Leukocytes | 2 | 2013 | 2034 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 7609 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2024 | 3411 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2013 | 239 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2001 | 1903 | 0.020 |
Why?
|
| Immunoblotting | 2 | 2006 | 1647 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 3714 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2004 | 1813 | 0.020 |
Why?
|
| Peroxidase | 2 | 2005 | 610 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2004 | 1990 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3814 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 2916 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 2460 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 1999 | 1326 | 0.020 |
Why?
|
| Enterohepatic Circulation | 1 | 2010 | 12 | 0.020 |
Why?
|
| Mice, Inbred CFTR | 1 | 2010 | 18 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2016 | 1137 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7472 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3621 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2015 | 840 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 2004 | 2360 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 3554 | 0.020 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 1969 | 23 | 0.020 |
Why?
|
| Gadolinium DTPA | 2 | 2003 | 823 | 0.020 |
Why?
|
| Abdominal Pain | 2 | 2009 | 1070 | 0.020 |
Why?
|
| Cell Line | 2 | 2014 | 15603 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2013 | 5905 | 0.020 |
Why?
|
| Duodenum | 2 | 2009 | 495 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1410 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 1991 | 386 | 0.020 |
Why?
|
| Electrophoresis | 1 | 1969 | 226 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 1904 | 0.020 |
Why?
|
| Base Sequence | 3 | 2004 | 12430 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2002 | 761 | 0.020 |
Why?
|
| Gene Silencing | 2 | 2008 | 1505 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2017 | 2674 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2014 | 1048 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2009 | 92 | 0.020 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1989 | 35 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 968 | 0.020 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2009 | 21 | 0.020 |
Why?
|
| Receptors, Somatomedin | 1 | 1989 | 57 | 0.020 |
Why?
|
| Neutrophils | 2 | 2015 | 3785 | 0.020 |
Why?
|
| DNA Primers | 2 | 2005 | 2827 | 0.020 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 1989 | 74 | 0.020 |
Why?
|
| Genomics | 1 | 2005 | 5928 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2008 | 5035 | 0.020 |
Why?
|
| Radiography | 1 | 2020 | 6991 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3433 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2008 | 104 | 0.020 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 26 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 395 | 0.020 |
Why?
|
| RNA | 2 | 2007 | 2727 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2010 | 2488 | 0.020 |
Why?
|
| Young Adult | 3 | 2024 | 60110 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2019 | 4251 | 0.020 |
Why?
|
| Interleukin-4 | 2 | 2002 | 1157 | 0.020 |
Why?
|
| Venous Pressure | 1 | 2008 | 55 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 393 | 0.020 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2008 | 105 | 0.020 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1988 | 71 | 0.020 |
Why?
|
| Gastrointestinal Hormones | 1 | 2008 | 101 | 0.020 |
Why?
|
| Cholesterol, Dietary | 1 | 2008 | 224 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 3744 | 0.020 |
Why?
|
| Cohort Studies | 5 | 2012 | 41800 | 0.020 |
Why?
|
| Transplantation, Homologous | 2 | 2008 | 4835 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2007 | 216 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 755 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2003 | 3626 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1989 | 1142 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2008 | 306 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2008 | 134 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2008 | 183 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2009 | 6546 | 0.020 |
Why?
|
| Pyruvate Kinase | 1 | 2009 | 190 | 0.020 |
Why?
|
| Heterozygote | 2 | 2007 | 2798 | 0.020 |
Why?
|
| Spleen | 2 | 2004 | 2294 | 0.020 |
Why?
|
| Nucleotides | 1 | 1969 | 455 | 0.020 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2007 | 61 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2008 | 2911 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2016 | 1982 | 0.020 |
Why?
|
| K562 Cells | 1 | 2008 | 648 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2014 | 3956 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7602 | 0.020 |
Why?
|
| Mice, SCID | 2 | 2002 | 2631 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2006 | 139 | 0.020 |
Why?
|
| Risk | 1 | 2019 | 9621 | 0.020 |
Why?
|
| RNA Editing | 1 | 2008 | 150 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2007 | 210 | 0.020 |
Why?
|
| Dopamine | 1 | 2014 | 1617 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2008 | 294 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2008 | 246 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 310 | 0.020 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2006 | 56 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2008 | 534 | 0.020 |
Why?
|
| Ploidies | 1 | 2007 | 287 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2695 | 0.020 |
Why?
|
| Carbon Tetrachloride | 1 | 2006 | 72 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 306 | 0.020 |
Why?
|
| Phylogeny | 1 | 2014 | 2843 | 0.020 |
Why?
|
| Neoplasms | 2 | 2005 | 22390 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 785 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2007 | 219 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2008 | 17174 | 0.020 |
Why?
|
| Phenotype | 4 | 2006 | 16735 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1989 | 17629 | 0.020 |
Why?
|
| Swine | 2 | 2007 | 5998 | 0.020 |
Why?
|
| Symporters | 1 | 2008 | 363 | 0.020 |
Why?
|
| Cyclin B | 1 | 2005 | 104 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 1609 | 0.020 |
Why?
|
| Burkitt Lymphoma | 1 | 1988 | 338 | 0.020 |
Why?
|
| Mastocytosis | 1 | 2007 | 150 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2007 | 346 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2003 | 26394 | 0.020 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2005 | 59 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2008 | 637 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2008 | 705 | 0.020 |
Why?
|
| Heart Failure | 1 | 2009 | 11879 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2008 | 582 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2007 | 562 | 0.020 |
Why?
|
| Base Pair Mismatch | 1 | 2004 | 93 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2020 | 3780 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2008 | 1585 | 0.010 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2004 | 69 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 2007 | 965 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2009 | 1616 | 0.010 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2004 | 40 | 0.010 |
Why?
|
| Incidental Findings | 1 | 2009 | 697 | 0.010 |
Why?
|
| Zebrafish | 2 | 2007 | 3037 | 0.010 |
Why?
|
| Trichosporon | 1 | 2004 | 9 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2009 | 1970 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1988 | 901 | 0.010 |
Why?
|
| Siblings | 1 | 2008 | 829 | 0.010 |
Why?
|
| Pathology, Molecular | 1 | 2007 | 329 | 0.010 |
Why?
|
| Thioguanine | 1 | 2003 | 45 | 0.010 |
Why?
|
| Hemangioendothelioma | 1 | 2004 | 112 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1339 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 930 | 0.010 |
Why?
|
| Species Specificity | 1 | 2008 | 2419 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2009 | 1337 | 0.010 |
Why?
|
| Killer Cells, Natural | 2 | 2004 | 2211 | 0.010 |
Why?
|
| Leukemic Infiltration | 1 | 2003 | 47 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 663 | 0.010 |
Why?
|
| Fallopian Tubes | 1 | 2004 | 179 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3629 | 0.010 |
Why?
|
| Autoantigens | 1 | 1988 | 891 | 0.010 |
Why?
|
| Daunorubicin | 1 | 2003 | 157 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1498 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5342 | 0.010 |
Why?
|
| Epidermis | 1 | 2006 | 539 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 1 | 2004 | 232 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2004 | 200 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3438 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2003 | 1399 | 0.010 |
Why?
|
| Proctoscopy | 1 | 2003 | 40 | 0.010 |
Why?
|
| Endosonography | 1 | 2007 | 626 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2009 | 2359 | 0.010 |
Why?
|
| Prednisolone | 1 | 2003 | 327 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2014 | 2905 | 0.010 |
Why?
|
| Point Mutation | 1 | 2008 | 1595 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2003 | 287 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2005 | 577 | 0.010 |
Why?
|
| Calcitonin | 1 | 2004 | 329 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 68 | 0.010 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2002 | 43 | 0.010 |
Why?
|
| Giant Cells | 1 | 2003 | 187 | 0.010 |
Why?
|
| Cattle | 1 | 2008 | 3820 | 0.010 |
Why?
|
| Splenectomy | 1 | 2004 | 392 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2006 | 567 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 911 | 0.010 |
Why?
|
| Apoptosis | 2 | 2008 | 9528 | 0.010 |
Why?
|
| Etoposide | 1 | 2003 | 639 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2004 | 615 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 2005 | 673 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2007 | 1830 | 0.010 |
Why?
|
| Homozygote | 1 | 2007 | 1779 | 0.010 |
Why?
|
| Suture Techniques | 1 | 2007 | 779 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 588 | 0.010 |
Why?
|
| Tyrosine | 1 | 2006 | 1427 | 0.010 |
Why?
|
| Graft vs Host Reaction | 1 | 2001 | 99 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2004 | 287 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 414 | 0.010 |
Why?
|
| Cell Movement | 1 | 2014 | 5216 | 0.010 |
Why?
|
| Collagen Type III | 1 | 2002 | 92 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 1769 | 0.010 |
Why?
|
| Reference Values | 1 | 2009 | 4941 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 1526 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 1073 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 943 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2002 | 217 | 0.010 |
Why?
|
| Cytarabine | 1 | 2003 | 697 | 0.010 |
Why?
|
| Interphase | 1 | 2002 | 227 | 0.010 |
Why?
|
| Cadherins | 1 | 2006 | 906 | 0.010 |
Why?
|
| Protein Phosphatase 1 | 1 | 2002 | 135 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2002 | 304 | 0.010 |
Why?
|
| Colon, Sigmoid | 1 | 2002 | 124 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 413 | 0.010 |
Why?
|
| Organ Size | 1 | 2006 | 2268 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 1855 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 2002 | 267 | 0.010 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2002 | 161 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2003 | 777 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2002 | 361 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2002 | 224 | 0.010 |
Why?
|
| Telomerase | 1 | 2006 | 753 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2006 | 1110 | 0.010 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 301 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2008 | 1812 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6242 | 0.010 |
Why?
|
| Binding Sites | 1 | 1989 | 6023 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2006 | 3076 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1988 | 6131 | 0.010 |
Why?
|
| Pancreatic Ducts | 1 | 2002 | 330 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2002 | 303 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1251 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2015 | 65485 | 0.010 |
Why?
|
| Polycythemia | 1 | 2001 | 124 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2010 | 2935 | 0.010 |
Why?
|
| Ovary | 1 | 2004 | 965 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2002 | 458 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 74971 | 0.010 |
Why?
|
| Bromocriptine | 1 | 1999 | 93 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2007 | 19023 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 1999 | 108 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2004 | 1836 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1988 | 2885 | 0.010 |
Why?
|
| Fibrosis | 1 | 2006 | 2081 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2004 | 761 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 5763 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2007 | 2937 | 0.010 |
Why?
|
| Abdominal Injuries | 1 | 2001 | 362 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2002 | 841 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2008 | 3233 | 0.010 |
Why?
|
| Albumins | 1 | 2001 | 577 | 0.010 |
Why?
|
| Cell Division | 1 | 2005 | 4478 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2004 | 1120 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2002 | 771 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2006 | 1535 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2004 | 1758 | 0.010 |
Why?
|
| Prolactin | 1 | 1999 | 627 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 5323 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1989 | 13427 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1999 | 337 | 0.010 |
Why?
|
| Ion Channels | 1 | 2002 | 1044 | 0.010 |
Why?
|
| Antigens | 1 | 2002 | 1444 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 2004 | 1172 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2004 | 1625 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 1209 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2005 | 9081 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2009 | 9682 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 8200 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 2004 | 0.010 |
Why?
|
| Colectomy | 1 | 2001 | 699 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2003 | 2088 | 0.010 |
Why?
|
| Erythropoietin | 1 | 2001 | 718 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2003 | 1126 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2008 | 2260 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2008 | 2831 | 0.010 |
Why?
|
| Diarrhea | 1 | 2003 | 1319 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4628 | 0.010 |
Why?
|
| Protein Binding | 1 | 1988 | 9344 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 8742 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2006 | 2606 | 0.010 |
Why?
|
| DNA Repair | 1 | 2004 | 2054 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6673 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4794 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12093 | 0.010 |
Why?
|
| Clostridium Infections | 1 | 2001 | 559 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2002 | 1093 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 4077 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 10641 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 1999 | 1019 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2002 | 2003 | 0.010 |
Why?
|
| Time Factors | 3 | 2004 | 40266 | 0.010 |
Why?
|
| Allergens | 1 | 2002 | 1444 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 6320 | 0.010 |
Why?
|
| Aging | 1 | 2012 | 8765 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 3659 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 15875 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8559 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 22294 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1999 | 1728 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 2892 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 23847 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2001 | 1483 | 0.010 |
Why?
|
| Carcinoma | 1 | 2002 | 2340 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1991 | 862 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1991 | 816 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 24330 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1969 | 81 | 0.010 |
Why?
|
| Dialysis | 1 | 1969 | 73 | 0.010 |
Why?
|
| Phosphorus Isotopes | 1 | 1969 | 125 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 1969 | 175 | 0.010 |
Why?
|
| Chemistry | 1 | 1969 | 327 | 0.010 |
Why?
|
| Acrylates | 1 | 1969 | 75 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1991 | 1553 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1969 | 486 | 0.010 |
Why?
|
| Methods | 1 | 1969 | 1066 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 4415 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1969 | 530 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1969 | 266 | 0.000 |
Why?
|
| Gels | 1 | 1969 | 422 | 0.000 |
Why?
|
| Survival Rate | 1 | 2002 | 12873 | 0.000 |
Why?
|
| Algorithms | 1 | 2007 | 14199 | 0.000 |
Why?
|
| Ribosomes | 1 | 1969 | 499 | 0.000 |
Why?
|
| Phosphates | 1 | 1969 | 765 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 12252 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 13699 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2001 | 15889 | 0.000 |
Why?
|
| United States | 1 | 2007 | 73180 | 0.000 |
Why?
|